Improving treatment for post-thrombotic syndrome using ultrasound techniques

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the clinical efficacy of ultrasound accelerated thrombolysis and venoplasty in patients suffering from post-thrombotic syndrome due to chronic femoro-popliteal vein occlusion following deep vein thrombosis (DVT). A total of 50 patients with lower extremity DVT, who have not responded to conservative treatments, will be enrolled at San Raffaele Hospital in Milan. The study aims to assess the effectiveness of these interventions in alleviating symptoms and improving venous flow in affected limbs.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Patient admitted in Vascular Surgery Unit, San Raffaele Hospital, Milan
* Patients able to sign specific informed consent for the study.
* Proximal deep vein Thrombosis (iliac vein, common femoral vein, deep femoral vein, and femoral vein) that was objectively diagnosed with duplex imaging and/or venography ≥ 6 months prior to study screening.
* Persistent chronic deep vein Thrombosis causing restrictive flow, as confirmed by imaging, within 60 days prior to the study procedure.
* Failed a minimum of 3 consecutive months of conservative treatment (therapeutic anticoagulation and compression stockings).
* Villalta score ≥8 for the affected limb within 30 days prior to the study procedure

Exclusion Criteria:

* Treated with mechanical thrombectomy within 2 weeks of the study thrombolysis procedure.
* Treated with thrombolysis drugs within 48 hours of the study thrombolytic procedure.
* Life expectancy less than (\<) 1 year.
* Body Mass Index (BMI) greater than (\>) 40 kilograms/square meter (kg/m\^2) or per Investigator's discretion participant is able tolerate the procedure and be compliant with post-procedure increased physical activity.
* No flow in popliteal vein on duplex imaging
* Thrombus extending ≥ 3 centimeters (cm) into the inferior vena cava (IVC). If central venous occlusion, consider computed tomography (CT) or magnetic resonance venography (MRV). For participants with bilateral DVT, it is recommended that central imaging be performed prior to treatment to evaluate the status of the IVC.
* Active bleeding, recent (\<3 months) gastrointestinal (GI) bleeding, active peptic ulcer, severe liver dysfunction, and bleeding diathesis.
* Recent (\<3 months) internal eye surgery or hemorrhagic retinopathy; recent (\<10 days) major surgery, cataract surgery, trauma, cardiopulmonary resuscitation (CPR), obstetrical delivery, or other invasive procedure.
* History of stroke or intracranial/intraspinal bleed, tumor, vascular malformation, or aneurysm.
* Active cancer (metastatic, progressive, or treated within the last 6 months). Participants with non-melanoma primary skin cancers are eligible to participate in the study.
* Hemoglobin \<9.0 milligrams/deciliter (mg/dL) within 24 hours prior to the procedure
* International normalized ratio (INR) ≥1.5 nanograms/deciliter (ng/dL) within 24 hours prior to the procedure.
* Platelet count \<100,000 cells/cubic millimeter (cells/mm\^3) or \>700,000 cells/mm\^3 within 24 hours prior to the procedure.
* Creatinine outside the normal range for the treating institution and considered clinically significant by the Investigator.
* Uncontrolled hypertension, defined as systolic \>175 millimeters of mercury (mmHg) and a diastolic \>110 mmHg.
* Use of clopidogrel, ticlopidine, or other thienopyridine antiplatelet drug within 7 days of the study procedure.
* In the judgment of the clinician, the participant is at high risk for catastrophic bleeding.
* Impossibility or refusal to give informed consent

Where it's running

• San Raffaele Hospital
  Milan, Italy, Italy Recruiting

Study contacts

• Study coordinator: Domenico Baccellieri, MD
• Email: baccellieri.domenico@hsr.it
• Phone: +39022643

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Effective Communication in VBAC Counseling

  This study tests how clearly doctors and midwives explain VBAC options during prenatal visits and whether patients feel understood.

  Recruiting IRCCS San Raffaele · Milan, MI · NCT07919145

• CAR-T Therapy Safety, Response, and Immune-Escape: Observational Study in Adults

  This observational study looks at adults who receive CAR-T cell therapy or bispecific antibodies to see which factors predict response and immune-related side effects.

  Recruiting IRCCS San Raffaele · Milan, Italy · NCT07915102

• Photon-counting CT versus traditional CT for suspected coronary artery disease

  This trial tests whether photon-counting CT can better diagnose obstructive CAD in people who need a coronary CTA than the standard energy-integrating detector CT.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07831304

• Intensive 4-week postoperative multimodal rehab after proximal pancreatic surgery

  This study tests whether a 4-week multimodal rehabilitation program can help adults who have severe complications after proximal pancreatic surgery recover better.

  Recruiting IRCCS San Raffaele · Milan · NCT07768384

• Engineered HMGB1 protein as a companion therapy for LAMA2-related muscular dystrophy

  This study tests how existing patient samples from people with LAMA2-related muscular dystrophy can be used to explore a potential companion therapy using an engineered HMGB1 protein.

  Recruiting IRCCS San Raffaele · Milan · NCT07745218

• OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases

  This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.

  Recruiting IRCCS San Raffaele · Milan, Milano · NCT07720765

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.